SA
PRFT logo
Perficient, Inc.(PRFT)
Last print 4 weeks agoAbout this dataData status
$75.96▲0.48 (0.64%)Stale · 4 weeks old
Extended:$75.97+0.01 (+0.01%)· 10:47 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Perficient, Inc. (PRFT)

Deferred Revenue

$1.60M

Quarterly · Period ending: · USD

PRFT logo

PRFT Deferred Revenue

Latest reported$5.50M
PRFT FY Deferred Revenue ($0.00 → $5.50M)
Powered by
High-resolution chart · PNG

What is deferred revenue?

Revenue received but not yet earned.

PRFT deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Perficient, Inc. Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)Change
5,500,000−56.66%
12,690,000+55.38%
8,167,000−13.32%
9,422,000+21.84%
7,733,000−4.66%
8,111,000+147.44%
3,278,000+4.46%
3,138,000−42.04%
5,414,000−8.93%
5,945,000+65.60%
3,590,000+20.71%
2,974,000+185.69%
1,041,000—
0—
0−100.00%
1,575,000+9.45%
1,439,000+9.18%
1,318,000—
0—
0—
0—
0—
0—
0—
0—
0—

Frequently asked questions: PRFT deferred revenue

What is Perficient, Inc. (PRFT)'s current deferred revenue?

Perficient, Inc. (PRFT)'s latest reported deferred revenue (Quarterly) is $1.60M as of Jun 30, 2024. Revenue received but not yet earned.

How much historical deferred revenue data is available for PRFT?

Stock Alarm Pro provides 26 dated annual fiscal periods observations for Perficient, Inc. (PRFT)'s deferred revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare PRFT's deferred revenue to peers or set an alert?

You can open PRFT's deferred revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on PRFT delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.